Meeting
2012 ASCO Annual Meeting
An exploratory study to determine if BRCA1 and BRCA2 mutation carriers have higher risk of cardiac toxicity.
Authors
Roohi Ismail-Khan
H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Roohi Ismail-Khan , Monique Sajjad , Weihong Sun , Hatem Hussein Soliman , Hyo S. Han , Susan E. Minton , Johnathan M. Lancaster , Tuya Pal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Epidemiology
Citation
J Clin Oncol 30, 2012 (suppl; abstr 1585)
DOI
10.1200/jco.2012.30.15_suppl.1585
Abstract #
1585
Poster Bd #
7C
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Association of anthracyclines induced cardiotoxicity (AIC) in patients with early breast cancer (eBC) with germline BRCA1/2 (gBRCA1/2) mutation: BRCAN study.
First Author: Juan José Serrano Domingo
Poster
2016 ASCO Annual Meeting
Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1).
First Author: Philipp Harter
Poster
2015 Breast Cancer Symposium
Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer.
First Author: Nimmi S. Kapoor
Poster
2012 Breast Cancer Symposium
Mutation analysis of PALB2 in high-risk and lower-risk patients negative for BRCA1 and BRCA2 mutations.
First Author: Shelly Cummings